CI
CI
Year ended Dec 31, 2024 · FY2025 10-K

The Cigna Group (CI) 10-K Summary — Year Ended Dec 31, 2024

The Cigna Group filed its annual report, showing a significant increase in revenue. The company continues to manage liquidity through subsidiary and parent-level strategies, while facing regulatory restrictions on dividend payments.

Key takeaway

Year ended Dec 31, 2024 · FY2025 10-K

The Cigna Group filed its annual report, showing a significant increase in revenue. The company continues to manage liquidity through subsidiary and parent-level strategies, while facing regulatory restrictions on dividend payments.

Financial snapshot

Selected annual figures reported with the filing, shown separately from the narrative summary.

Annual revenue

$247.1B

Revenue reported for the fiscal year.

Operating income

$9.4B

Income from operations reported for the year.

Net income

$3.4B

Net income reported for the year.

Operating cash flow

$10.4B

Cash generated by operating activities.

Annual revenue trend

Reported annual revenue and its change from the preceding fiscal year.

Period endedRevenueYear-over-year change
Dec 31, 2021$174.1Bn/a
Dec 31, 2022$180.5B+3.7%
Dec 31, 2023$195.3B+8.2%
Dec 31, 2024$247.1B+26.6%

Business overview

The company operates in health services, managing pharmacy, medical costs, and insurance/HMO operations. It maintains liquidity at two levels and is subject to regulatory constraints on dividends from its insurance subsidiaries.

Financial performance

Revenue grew compared to the prior year, and the company reported positive operating income, net income, and operating cash flow. The financial metrics indicate a strong operational performance for the period.

Material risks

A key risk is the regulatory restriction on dividends from insurance and HMO subsidiaries, which could limit the parent company's access to cash. Other risks are referenced in the filing but not detailed in the provided context.

Liquidity and capital

The company manages capital by maintaining cash and investments at both subsidiary and parent levels, using operating cash flows, borrowing, and dividends from subsidiaries within regulatory limits.

What to watch

The next filing should be monitored for any changes in the company's revenue growth trajectory and the impact of regulatory restrictions on subsidiary dividends.

The Cigna Group (CI) 10-K Summary — Year Ended Dec 31, 2024